Bangkok Dusit Medical Services Public Company Limited (SET: BDMS) has announced its 3Q24 consolidated financial statement through the Stock Exchange of Thailand as follows:
| Quarter | 3Q24 | 3Q23 |
| Net Profit (Loss) Million Baht |
4,246.04 | 3,884.48 |
| Earning Per Share (Baht) |
0.2700 | 0.2400 |
| % Change | 9.31 | |
| 9 Months | 9M24 | 9M23 |
| Net Profit (Loss) Million Baht |
11,654.41 | 10,404.02 |
| Earning Per Share (Baht) | 0.73 | 0.65 |
| % Change | 12.02 | |
BDMS reported a net profit of Baht 4,246 million in 3Q24, increased by 9% YoY due mainly to growth of Thai and international patients as well as an effective financial management to reduce interest expense.
In the third quarter, the company reported consolidated operating income for the third quarter of 2024 of Baht 28,536 million, an increase of 7% from 3Q23. The growth was mainly attributable to an increase in revenue from hospital operations of 6% YoY which was driven by Thai patient revenues growth of 6% YoY together with international patient revenues growth of 8% YoY.
In 3Q24, the Company and its subsidiaries reported total operating expenses & depreciation of Baht 22,947 million, an increase of Baht 1,372 million or 6% YoY. The total operating expenses & depreciation increased mainly from higher doctor fees, drug and medical supply cost resulting from the growth in revenue from hospital operations, as well as increased clinical & non-clinical staff expenses and other administration expenses.
